Article

Rapid Genome Sequencing Compared to a Gene Panel in Critically Ill Infants with a Suspected Genetic Disorder: An Economic Evaluation

2024-10-18

Abstract excerpt

<h4>Introduction</h4> Rapid genome sequencing (rGS) provides high diagnostic yield for critically ill infants with suspected genetic disorders, but has high upfront costs and insufficient insurance coverage. Assessing the downstream costs and health outcomes associated with rGS is important for guiding coverage decisions. This study compares 1-year healthcare costs and quality-adjusted life years (QALYs) for: 1) e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe9d90a4-1189-52b5-81d8-cce3a8d83400
DOI: 10.1101/2024.10.18.24315740

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid Genome Sequencing Compared to a Gene Panel in Critically Ill Infants with a Suspected Genetic Disorder: An Economic EvaluationDOI 10.1101/2024.10.18.24315740Read

Rapid Whole Genome Sequencing Decreases Morbidity and Healthcare Cost of Hospitalized InfantsSemantic proximity Read

Rapid genome sequencing for critically ill infants: an inaugural pilot study from TurkeySemantic proximity Read

Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a reviewSemantic proximity Read

SeqFirst: Building equity access to a precise genetic diagnosis in critically ill newborns.Semantic proximity Read

SeqFirst: Building equity access to a precise genetic diagnosis in critically ill newbornsSemantic proximity Read

Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditionsSemantic proximity Read

Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.Semantic proximity Read

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the NetherlandsSemantic proximity Read

A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseasesSemantic proximity Read

The NSIGHT1 Randomized Controlled Trial: Rapid Whole Genome Sequencing for Accelerated Etiologic Diagnosis in Critically Ill InfantsSemantic proximity Read

The Role of Genome Sequencing in Neonatal Intensive Care UnitsSemantic proximity Read

Rapid Whole Genome Sequencing in Critically Ill Neonates Enables Precision Medicine PipelineSemantic proximity Read